EVIDENCE BASED DECISION MAKING FOR THE RATIONAL DRUG LIST (RDL) DR MAISA AL SAKET DG JOINT PROCUREMENT DEPARTMENT  Committ...
Members of Committee  2 <ul><li>Dr Maisa Al Saket/ G.D. - JPD </li></ul><ul><li>Dr Riham Al Natheef/ Supply Director- RMS ...
Background <ul><li>There will be a transparent evidence- based process in place for listing drugs </li></ul><ul><li>Conduc...
MeTA Work plan- Jordan  <ul><li>Encouraging best practice/ improve rational use of medicines </li></ul><ul><li>Evidence ba...
Evidence- based decision making  can be achieved through: <ul><li>Assessment of Current Committees’ constitution, TOR and ...
Assessment of Current Committees’ constitution, TOR and Procedures sub-activities: <ul><li>Review constitutions, TOR and S...
Assessment of current  classification of drugs <ul><li>Formulate a technical working group to review the  classification o...
Technical working group represents <ul><li>JFDA/ RDU </li></ul><ul><li>JPD </li></ul><ul><li>Ministry of Health/ Clinical ...
Raising awareness among stakeholders and building capacity <ul><li>Organize  workshops to  raise awareness and reach a com...
Monitoring and Evaluation <ul><li>Monitor and Evaluate  the adoption and implementation of recommendations in previous act...
Evidence- based decision making activities KPI’s  include: <ul><li>Constitution, TOR & SOPs for committees are in place </...
Thank you  10/06/09 MeTA
Upcoming SlideShare
Loading in …5
×

Evidence based decision making for the rational drug list (RDL)

1,627 views

Published on

Presentation by Dr Maisa Al Saket, Director General of the Joint Procurement Department and chair of the National MeTa Council's Committee on Evidence-based Decision making for the Rational Drug List, at the launch of MeTA Jordan in May 2009.

Published in: Health & Medicine, Education
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,627
On SlideShare
0
From Embeds
0
Number of Embeds
5
Actions
Shares
0
Downloads
21
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • Title of presentation 10/06/09 MeTA
  • Evidence based decision making for the rational drug list (RDL)

    1. 1. EVIDENCE BASED DECISION MAKING FOR THE RATIONAL DRUG LIST (RDL) DR MAISA AL SAKET DG JOINT PROCUREMENT DEPARTMENT Committee 2 Evidence Based MeTA 10/06/09
    2. 2. Members of Committee 2 <ul><li>Dr Maisa Al Saket/ G.D. - JPD </li></ul><ul><li>Dr Riham Al Natheef/ Supply Director- RMS </li></ul><ul><li>Dr Musallam Qatarneh/ Purchasing & Supply Director/ MOH </li></ul><ul><li>Dr Ibrahim Abbadi/ Jordan University </li></ul><ul><li>Dr Lama Al Homoud/ Clinical Pharmacy Director - MOH </li></ul><ul><li>Dr Hanan Sboul/ SG. - JAPM </li></ul>10/06/09 MeTA
    3. 3. Background <ul><li>There will be a transparent evidence- based process in place for listing drugs </li></ul><ul><li>Conducting Pharmaco-economic studies is crucial for the development of an effective and affordable national drug list </li></ul><ul><li>It is crucial that the public health institutions are supportive of the process and believe in the integrity of the final RDL in order to promote the adherence to it by prescribers and institutions   </li></ul>10/06/09 MeTA
    4. 4. MeTA Work plan- Jordan <ul><li>Encouraging best practice/ improve rational use of medicines </li></ul><ul><li>Evidence based decision making for the rational drug list RDL </li></ul><ul><li>Capacity building in Civil society </li></ul>10/06/09 MeTA
    5. 5. Evidence- based decision making can be achieved through: <ul><li>Assessment of Current Committees’ constitution, TOR and Procedures </li></ul><ul><li>Assessment of current classification of drugs </li></ul><ul><li>Raising awareness among stakeholders and building capacity </li></ul><ul><li>Monitoring & evaluation </li></ul>10/06/09 MeTA
    6. 6. Assessment of Current Committees’ constitution, TOR and Procedures sub-activities: <ul><li>Review constitutions, TOR and SOPs of various committees involved in the selection of drugs in the RDL (requires COI declaration, and COI guidelines) and benchmark against best practices </li></ul><ul><li>Recommend regulations for the amendments- if needed </li></ul><ul><li>Review criteria for adding and deleting drugs to and from the RDL </li></ul><ul><li>Recommend evidence based regulations for the addition / deletion criteria </li></ul><ul><li>Adopt the recommendations </li></ul>10/06/09 MeTA
    7. 7. Assessment of current classification of drugs <ul><li>Formulate a technical working group to review the classification of drugs (restricted, unrestricted & authority required) in the RDL </li></ul><ul><li>Recommend detailed evidence based regulations for the implementation of the classification of drugs </li></ul><ul><li>Adopt the classification & the detailed regulations for the implementation of the classification </li></ul>10/06/09 MeTA
    8. 8. Technical working group represents <ul><li>JFDA/ RDU </li></ul><ul><li>JPD </li></ul><ul><li>Ministry of Health/ Clinical Pharmacy , Supply Departments </li></ul><ul><li>Royal Medical Services/ Drug &Pharmacy, Supply Departments </li></ul><ul><li>Academia/ PhD in clinical pharmacy </li></ul><ul><li>Internal medicine consultant </li></ul><ul><li>Pharmaco-economist </li></ul>10/06/09 MeTA
    9. 9. Raising awareness among stakeholders and building capacity <ul><li>Organize workshops to raise awareness and reach a common understanding on the concepts of role of pharmacy & therapeutic committee (PTC), evidence-based medicine (EBM), pharmaco-economics, transparency & accountability </li></ul><ul><li>Train policy makers and technical committees in NICE/UK </li></ul><ul><li>Organize workshop on use of cost effectiveness tools </li></ul>10/06/09 MeTA
    10. 10. Monitoring and Evaluation <ul><li>Monitor and Evaluate the adoption and implementation of recommendations in previous activities, according to set KPI’s </li></ul>10/06/09 MeTA
    11. 11. Evidence- based decision making activities KPI’s include: <ul><li>Constitution, TOR & SOPs for committees are in place </li></ul><ul><li>Guidelines for addition/ deletion & classification are in place </li></ul><ul><li>Workshops conducted </li></ul><ul><li>Reports to be delivered </li></ul>10/06/09 MeTA
    12. 12. Thank you 10/06/09 MeTA

    ×